HISAMITSU PHARMACEUTICAL CO.,INC. (4530) Other
Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
| 2012/02 | 2013/02 | 2014/02 | 2015/02 | 2016/02 | 2017/02 | 2018/02 | 2019/02 | 2020/02 | 2021/02 | 2022/02 | 2023/02 | 2024/02 | 2025/02 | 2026/02 | |
| Return on Assets | - | - | - | - | 6.2 | 7.3 | 6.7 | 6.5 | 6.3 | 3.1 | 3.3 | 3.9 | 4.5 | 6.6 | 2.6 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 2,718 | 2,826 | 2,949 | 2,942 | 2,900 | 2,751 | 2,823 | 2,792 | 2,745 | 2,770 | 2,784 | 2,769 | 2,759 | 2,799 | - |
| Total payout ratio | - | - | - | 35.4 | 63.2 | 88.1 | 35.5 | 67.4 | 60 | 72.2 | 150.9 | 118.9 | 113.5 | 76.6 | 214.9 |